99.9% Efficacy Against SARS Covid-2 (Covid 19)
Protection for today ... and tomorrow!
Welcome to N-PE, the global leader in Non-Toxic Pathogen Eradication! NPEs Path-Away products have been Diffused through the Ventilation Systems And Fogged During Building Occupancy for more than 12 years, in more than 4,000 buildings around the world!
Path-Away has a 12 year history of solving the most complex Viral Pathogen problems and was used to halt the H1N1 Virus during the Swine Flu Pandemic and is in Hospitals, Schools, Universities, Retail Operations, Private Airlines, Cruise Ships, Textile Industries, Apartments, Condos, Public Gyms, High Rise Buildings, Office Buildings, Commercial Buildings, Private Medical Clinics, Poultry Industry,
Assisted Living Centers, Hotels, Bars, Restaurants, Meat Processing Plants, and fogged in National Brand chains such as Macy’s and Philip Van Huesen’s 800 Retail Locations — Path-Away is hard at work 24/7 365 Days A Year killing Viral, Bacterial, Mold, and Fungal Pathogens.
From the United States to Thailand, Indonesia, Malaysia, Singapore, Philippines, Saudi Arabia, Netherlands, New Zealand, Nigeria, Kenya,
Australia, U.K., Canada, Bangladesh, Columbia, and Panama…Path-Away Performs in all climates with a LAB CERTIFIED LOG 4 EFFICACY (99.99% Kill Rate) In LESS THAN ONE MINUTE!
N-PE offers pathogen eradication barriers using Path-Away. Path-Away is a broad spectrum Nontoxic, Non-GMO, Biodegradable, Viral, Bacterial, Mold and Fungal Eradication Solution through a continuous delivery diffusion system (M3 (Patent Pending)) tied into your HVAC system, fogged, or sprayed in your offices and on with our personal care line directly to the human exposure pathways to create a Kill Barrier against more than 170 Pathogens including SARS-COV-2 (COVID – 19).
What does N-PEs Path-Away product do for our clients and where do I buy it?
To answer this question we have to first explain what infectious agents are and how in a worse case scenario they transmit and act in the body. The exposure pathways for a infectious or any other pathogens to enter a
human being are simple, eyes, nose, mouth, or open wound.
COVID – 19 In the body.
Since we are in the middle of a pandemic, lets use SARS-COV-2 (COVID-19) as an example. SARS-COV-2 has a GP120 “Docking Protein” and GP120 in simple terms is the glycoprotein first noted in the HIV Virus. This GP120 Docking Protein makes your CD4 cells more susceptible to invasion by the virus. Since CD4 cells are involved intimately in your innate immune response, crippling them with viral infections leads to increased susceptibility to other infections and ultimately the host gets sick. While the presence of the GP120 Docking Protein may not be as life threatening with COVID-19 as is the case with HIV it is certainly a new addition that enhances the armamentarium of the virus thus in turn making it more difficult to kill COVID 19 once it penetrates the body through the exposure pathways.
Transmissibility. Infectious agents have discrete size ranges. COVID-19 is in fact highly infectious. As a virus it is in the ~0.02-0.30 μm size range. That makes it gravimetrically light and allows it to stay in suspension in air for a good period of time. Their size changes as they are aerosolized and exposed to environmental factors RH, temperature) that favor desiccation or hygroscopicity. With rapid desiccation, the resultant smaller aerosols can remain airborne longer.
Particle size and shape determine the behavior of the agent suspended in air. Airborne particles, regardless of size or shape are referred to in terms of their equivalent (or aerodynamic) diameter. Particle bulk density is important relative to gravitational settling velocity. Generally, it is considered that particles up to 100 μm in diameter are capable of remaining airborne long enough to be observed or measured as aerosols and hence able to transmit infectious agents. Droplet aerosols <100 μm can remain suspended for prolonged periods of time because typical room air velocities exceed the terminal settling velocities of the particles. COVID-19, with a size range of 0.02-0.30 μm fits the profile of an airborne transmitted pathogen perfectly.
The Solution. With SARS-COV-2 vaccines 18 months away in a best-case scenario we are left with stopping COVID – 19 BEFORE it reaches the exposure pathways and provide a KILL barrier on the exposure pathways in the event the virus does reach the exposure pathways.
The Answer – The Path-Away Barrier. Pathaway is a broad spectrum Nontoxic, Non-GMO, Biodegradable, Viral, Bacterial, Mold and Fungal Eradication Solution through a continuous delivery diffusion system (M3) tied into your HVAC system, fogged, or sprayed in and around the human pathways (Eyes, nose, mouth, or open wounds) that provides a barrier of protection that KILLS COVID – 19 and other pathogens on contact.
Where To Purchase Path-Away. Please visit our product description and purchase page. (Products Page).